切換帳號

  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 登入

全站搜尋

台灣泌尿科醫學會E-School
  • 登入
  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 到官網
  • Home
  • 到官網
  • Home
知識庫
  • 目錄總覽
  • 文件總覽
  • 最新討論
目錄 / 資料夾
  • 學術活動與演講
    • 年會
      • 2026半年會
        • 摘要
      • 2025年會 (UAA)
        • 摘要
      • 2025半年會
        • 摘要
      • 2024年會
        • 摘要
      • 2024半年會
        • 摘要
      • 2023年會
        • 摘要
      • 2023半年會
        • 摘要
      • 2022年會
        • 摘要
      • 2021年會
        • 摘要
      • 2021半年會
        • 摘要
      • 2020年會
        • 摘要
      • 2020半年會
        • 摘要
      • 2019年會
        • 摘要
      • 2019半年會
        • 摘要
      • 2018年會
        • 摘要
      • 2018半年會
        • 摘要
      • 2017年會
        • 摘要
      • 2017半年會
        • 摘要
      • 2016年會
        • 摘要
      • 2016半年會
        • 摘要
      • 2015年會
        • 摘要
  • 新手指南與FAQ
  1. 知識庫
  2. 最新上傳

最新上傳
(
  • 熱門
)

最新上傳

(
  • 熱門
)
PD09-3: Safety and efficacy of intravesical epinephrine instillation for patients with intractable bladder hemorrhage
2020-06-09
PD09-2: Can donor Tc-99m diethylene triamine pentaacetic acid renal scan predict graft function recovery in living donor kidney transplant?
2020-06-09
PD09-1: Management of transplant renal artery stenosis: Two case reports and literature review
2020-06-09
PD08-6: How is your RNA/DNA quality and sample viability from your resected tumour?
2020-06-09
PD08-5: Pheochromocytoma: the “ten-percent” malignant tumor? Ki-67 as an independent factor for recurrence or metastasis
2020-06-09
PD08-3: MicroRNA-214 in upper tract urothelial carcinoma and its effect on tumor cell behaviour by targeting CSF-1
2020-06-09
PD08-2: Transfer of prothymosin-α in cancer-derived exosome triggers muscle atrophy in cancer cachexia via TLR4-NF-κB-E3 ubiquitin ligase signaling pathway
2020-06-09
PD08-1: The prognostic impact of lymph node dissection for upper urinary tract urothelial carcinoma in patient with clinically node-negative disease
2020-06-09
PD07-6: The mechanism of miR-30a-3p/MMP2 system regulates cell invasion and tumor growth in baldder cancer
2020-06-09
PD07-5: Influence of body mass index on the prognosis of patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
2020-06-09
PD07-4: Cis-platinum induces immunity evasion through PD-L1 upregulation in bladder cancer cells
2020-06-09
PD07-2: Kidney sparing surgery preserves renal function without compromising oncological outcome: An inverse probability of treatment weighting analysis in upper tract urothelial carcinoma
2020-06-09
PD07-1: High Transaldolase 1 (TALDO1) expression predicts poor survival of upper tract urothelial carcinoma patients
2020-06-09
PD06-5: Urothelial cell proliferation, cytoskeleton and barrier function protein expression in the female patients with different phenotypes of urinary tract infection
2020-06-09
PD06-6: Age- and gender-specific nomograms of post-void residual urine in healthy children and adolescents
2020-06-09
PD06-4: Videourodynamics analysis of the lower urinary tract dysfunctions in patients with chronic brain disorders
2020-06-09
PD06-3: Will detrusor acontractile recover after medical or surgical treatment?A longitudinal long tern urodynamic follow-up
2020-06-09
PD06-2: The urothelial cytoskeleton and cell proliferation protein expression in intersitial cystitis/bladder pain syndrome patients of different phenotype
2020-06-09
PD06-1: Prader-Willi Syndrome patients and low urinary tract dysfunction
2020-06-09
PD05-6: Combined immune checkpoint inhibitors in the frontline treatment of metastatic renal cell carcinoma—a real-world experience
2020-06-09
PD05-5: The effect of Metastasectomy on overall survival in metastatic renal cell carcinoma: systemic review and meta-analysis
2020-06-09
PD05-4: Active contour model of machine learning to evlauate the kidney cancer
2020-06-09
PD05-3: Pathological node-positive renal cell carcinoma is associated with worse survival outcome: A recall for TMN staging revision
2020-06-09
PD05-2: Tumor Volume, time to PSA nadir and PSA decline rate influence outcomes in metastatic prostate cancer receiving androgen deprivation therapy
2020-06-09
  • <
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • >
/ 155
地址:台北市 11051 信義區基隆路一段432號6樓之1, 電話:02-2729-0819, 傳真:02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw